Rockingstone Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Rockingstone Advisors's LLY Position: Q3 2026 in Review
Rockingstone Advisors increased its Eli Lilly (LLY) stake by 0.14% in Q3 2026, buying an estimated $5.9K and bringing the position to 3,617 shares worth $4.19M. The position accounts for 1.68% of the portfolio, ranked #20.
Rockingstone Advisors first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.33M in Q2 2026. 2,227 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Rockingstone Advisors held 3,617 shares of Eli Lilly worth $4.19M as of Q3 2026.
- Rockingstone Advisors bought 5 Eli Lilly shares in Q3 2026, an estimated $5.9K.
- Eli Lilly made up 1.68% of Rockingstone Advisors's portfolio in Q3 2026, its #20 holding.
- Rockingstone Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
- Rockingstone Advisors's Eli Lilly position peaked at $4.33M in Q2 2026.
- 2,227 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Rockingstone Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.